Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7

被引:19
|
作者
Inamoto, S.
Iwata, S.
Inamoto, T.
Nomura, S.
Sasaki, T.
Urasaki, Y.
Hosono, O.
Kawasaki, H.
Tanaka, H.
Dang, N. H.
Morimoto, C.
机构
[1] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, Tokyo 1088639, Japan
[2] Osaka Med Coll, Dept Med, Osaka, Japan
[3] Nevada Canc Inst, Dept Hematol Malignancies, Las Vegas, NV USA
关键词
Cas-L; Smad6; Smad7; TGF-beta; cancer;
D O I
10.1038/sj.onc.1209848
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Crk-associated substrate lymphocyte type (Cas-L) is a 105 kDa docking protein with diverse functional properties, including regulation of cell division, proliferation, migration and adhesion. Cas-L is also involved in beta 1 integrin- or antigen receptor-mediated signaling in B and T cells. In the present study, we demonstrate that Cas-L potentiates transforming growth factor-beta (TGF-beta) signaling pathway by interacting with Smad6 and Smad7. Immunoprecipitation experiments reveal that single domain deletion of full-length Cas-L completely abolishes its docking function with Smad6 and Smad7, suggesting that the natural structure of Cas-L is necessary for its association with Smad6 and Smad7. On the other hand, both N-terminal and C-terminal deletion mutants of Smad6 and Smad7 still retain their docking ability to Cas-L, suggesting that Smad6 and Smad7 possess several binding motifs to Cas-L. Moreover, Cas-L interaction with Mad-homology (MH)2 domain, but not with MH1 domain of Smad6 or Smad7, ameliorates TGF-beta-induced signaling pathway. Finally, depletion of Cas-L by small-interfering RNA oligo attenuates TGF-beta-induced growth inhibition of Huh-7 cells, with a concomitant reduction in phosphorylation of Smad2 and Smad3. These results strongly suggest that Cas-L is a potential regulator of TGF-beta signaling pathway.
引用
收藏
页码:893 / 904
页数:12
相关论文
共 50 条
  • [1] Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7
    S Inamoto
    S Iwata
    T Inamoto
    S Nomura
    T Sasaki
    Y Urasaki
    O Hosono
    H Kawasaki
    H Tanaka
    N H Dang
    C Morimoto
    Oncogene, 2007, 26 : 893 - 904
  • [2] Mutation analysis of transforming growth factor β type II receptor, Smad2, Smad4, Smad6 and Smad7 in hepatocellular carcinoma
    Kawate, S
    Ohwada, S
    Takeyoshi, I
    Kawashima, Y
    Ogawa, T
    Iwazaki, S
    Nakasone, Y
    Koyama, T
    Sunose, Y
    Mogi, A
    Shitara, Y
    Takenoshita, S
    GASTROENTEROLOGY, 1999, 116 (04) : A434 - A435
  • [3] Smad7 and Smad6 differentially modulate transforming growth factor β-induced inhibition of embryonic lung morphogenesis
    Zhao, JS
    Shi, W
    Chen, H
    Warburton, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) : 23992 - 23997
  • [4] Smad7 differentially regulates transforming growth factor β-mediated signaling pathways
    Zhu, Hong-Jian
    Iaria, Josephine
    Sizeland, Andrew M.
    Journal of Biological Chemistry, 274 (45): : 32258 - 32264
  • [5] Smad7 differentially regulates transforming growth factor β-mediated signaling pathways
    Zhu, HJ
    Iaria, J
    Sizeland, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) : 32258 - 32264
  • [6] Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-β Signaling
    Yan, Xiaohua
    Lin, Zhenghong
    Chen, Feng
    Zhao, Xingang
    Chen, Hua
    Ning, Yuanheng
    Chen, Ye-Guang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (44) : 30097 - 30104
  • [7] The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling
    Hanyu, A
    Ishidou, Y
    Ebisawa, T
    Shimanuki, T
    Imamura, T
    Miyazono, K
    JOURNAL OF CELL BIOLOGY, 2001, 155 (06): : 1017 - 1027
  • [8] Mutation analysis of transforming growth factor beta type I receptor, type II receptor, Smad2, Smad4, Smad6 and Smad7 in hepatocellular carcinoma.
    Kawate, S
    Ohwada, S
    Kunihiro, H
    Koyama, T
    Sakamoto, I
    Yoshinari, D
    Kasahara, M
    Tomizawa, N
    Kawashima, Y
    Takeyoshi, I
    Morishita, Y
    GASTROENTEROLOGY, 2000, 118 (04) : A1456 - A1456
  • [9] Effect of transforming growth factor-β3 on the expression of Smad3 and Smad7 in tenocytes
    Jiang, Ke
    Chun, Guo
    Wang, Ziming
    Du, Quanyin
    Wang, Aimin
    Xiong, Yan
    MOLECULAR MEDICINE REPORTS, 2016, 13 (04) : 3567 - 3573
  • [10] Smad7, but not Smad6, inhibits transforming growth factor beta-mediated growth inhibition and differentiation in vascular smooth muscle cells
    Kato, S
    Ueda, S
    Tamaki, K
    Fujii, M
    ten Dijke, P
    Miyazono, K
    Okuda, S
    Morimatsu, M
    CIRCULATION, 1999, 100 (18) : 616 - 616